US HB6977 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on January 11 2024 - 25% progression
Action: 2024-01-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 11 2024 - 25% progression
Action: 2024-01-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Public Health Service Act to provide for a demonstration project for the development and publication of independent value assessments for drugs, and for other purposes.
Title
Independent Drug Value Assessment Act of 2024
Sponsors
| Rep. Jerrold Nadler [D-NY] | Rep. Katie Porter [D-CA] | Rep. Shri Thanedar [D-MI] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-01-12 | House | Referred to the Subcommittee on Health. |
| 2024-01-11 | House | Referred to the House Committee on Energy and Commerce. |
| 2024-01-11 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/6977/all-info |
| Text | https://www.congress.gov/118/bills/hr6977/BILLS-118hr6977ih.pdf |
